Terms: = Lung cancer AND HIST1H3B, H3_1, P68431, H3FJ, H3/j, H3FF, H3/f, H3_f, H3FK, H3F1K, H3/k, H3FH, H3/h, H3FI, H3/i, H3FD, H3/d, H3FB, H3/b, H3FC, H3/c, H3FL, H3/l, H3FA, H3/A, ENSG00000124693, 8358 AND Treatment
6 results:
1. Characterization of histone chaperone MCM2 as a key regulator in arsenic-induced depletion of H3.3 at genomic loci.
Wu P; Lin SJ; Chen D; Jin C
Toxicol Appl Pharmacol; 2023 Oct; 477():116697. PubMed ID: 37734572
[TBL] [Abstract] [Full Text] [Related]
2. Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
Hooper AT; Marquette K; Chang CB; Golas J; Jain S; Lam MH; Guffroy M; Leal M; Falahatpisheh H; Mathur D; Chen T; Kelleher K; Khandke K; Muszynska E; Loganzo F; Rosfjord E; Lucas J; Kan Z; Subramanyam C; O'Donnell C; Neri D; Gerber HP; May C; Sapra P
Mol Cancer Ther; 2022 Sep; 21(9):1462-1472. PubMed ID: 35793468
[TBL] [Abstract] [Full Text] [Related]
3. B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.
Yang S; Wei W; Zhao Q
Int J Biol Sci; 2020; 16(11):1767-1773. PubMed ID: 32398947
[TBL] [Abstract] [Full Text] [Related]
4. The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.
Sheng J; Yang Y; Ma Y; Yang B; Zhang Y; Kang S; Zhou T; Hong S; Qin T; Hu Z; Fang W; Huang Y; Zhang L
PLoS One; 2015; 10(6):e0127306. PubMed ID: 26034985
[TBL] [Abstract] [Full Text] [Related]
5. Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells.
Brazelle W; Kreahling JM; Gemmer J; Ma Y; Cress WD; Haura E; Altiok S
PLoS One; 2010 Dec; 5(12):e14335. PubMed ID: 21179472
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model.
Guo W; Zhang Y; Chen T; Wang Y; Xue J; Zhang Y; Xiao W; Mo X; Lu Y
J Cancer Res Clin Oncol; 2011 Jan; 137(1):65-72. PubMed ID: 20336315
[TBL] [Abstract] [Full Text] [Related]
